{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:49:26Z","timestamp":1791910166780,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejso.2022.08.025","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T18:02:05Z","timestamp":1661709725000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-9951","authenticated-orcid":false,"given":"Andrew","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syem K.","family":"Barakzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-5109","authenticated-orcid":false,"given":"Marcia A.","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-4414","authenticated-orcid":false,"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.08.025_bib1","unstructured":"Cervical cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. <https:\/\/www.nccn.org> (accessed 4\/27\/2022)."},{"key":"10.1016\/j.ejso.2022.08.025_bib2","unstructured":"Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. <https:\/\/www.nccn.org> (accessed 4\/27\/2022)."},{"key":"10.1016\/j.ejso.2022.08.025_bib3","unstructured":"Vulvar cancer (squamous cell carcinoma). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. <https:\/\/www.nccn.org> (accessed 4\/27\/2022)."},{"key":"10.1016\/j.ejso.2022.08.025_bib4","unstructured":"Bladder cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. <https:\/\/www.nccn.org> (accessed 4\/27\/2022)."},{"key":"10.1016\/j.ejso.2022.08.025_bib5","unstructured":"Anal carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. https:\/\/www.nccn.org (accessed 4\/27\/2022)."},{"key":"10.1016\/j.ejso.2022.08.025_bib6","unstructured":"Rectal cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Version 1.2022, National Comprehensive Cancer Network. <https:\/\/www.nccn.org> (accessed 4\/27\/2022)."},{"issue":"5","key":"10.1016\/j.ejso.2022.08.025_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djr533","article-title":"Second malignant neoplasms and cardiovascular disease following radiotherapy","volume":"104","author":"Travis","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.025_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"issue":"30","key":"10.1016\/j.ejso.2022.08.025_bib9","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","article-title":"Second malignant neoplasms: assessment and strategies for risk reduction","volume":"30","author":"Wood","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.08.025_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/cncr.29841","article-title":"Therapeutic radiation and the potential risk of second malignancies","volume":"122","author":"Kamran","year":"2016","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2022.08.025_bib11","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3390\/ijerph9124744","article-title":"Second malignant neoplasms following radiotherapy","volume":"9","author":"Kumar","year":"2012","journal-title":"Int J Environ Res Publ Health"},{"issue":"17","key":"10.1016\/j.ejso.2022.08.025_bib12","first-page":"1113","article-title":"[Therapy of eczematous diseases in general practice]","volume":"95","author":"Meinhof","year":"1977","journal-title":"Fortschr Med"},{"issue":"5 Pt 1","key":"10.1016\/j.ejso.2022.08.025_bib13","first-page":"941","article-title":"Development of endometrial cancer after radiation treatment for cervical carcinoma","volume":"101","author":"Pothuri","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.025_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ygyno.2006.05.039","article-title":"Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers","volume":"103","author":"Pothuri","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.ejso.2022.08.025_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/AOG.0b013e3181954c5b","article-title":"Radiation-associated endometrial cancer","volume":"113","author":"Kumar","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"43","key":"10.1016\/j.ejso.2022.08.025_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001803","article-title":"Secondary primary malignancy risk in patients with cervical cancer in Taiwan: a nationwide population-based study","volume":"94","author":"Teng","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.025_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2018.08.035","article-title":"Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer","volume":"151","author":"Matsuo","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.025_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31661","article-title":"Association of radiotherapy for rectal cancer and second gynecological malignant neoplasms","volume":"4","author":"Guan","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.025_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/bjs.10327","article-title":"Risk of second primary cancer in patients treated with radiotherapy for rectal cancer","volume":"104","author":"Martling","year":"2017","journal-title":"Br J Surg"},{"issue":"40","key":"10.1016\/j.ejso.2022.08.025_bib20","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.3748\/wjg.v24.i40.4586","article-title":"Second primary malignancy risk after radiotherapy in rectal cancer survivors","volume":"24","author":"Wang","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.025_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.radonc.2017.02.007","article-title":"Secondary malignancies after rectal cancer resection with and without radiation therapy: a propensity-adjusted, population-based SEER analysis","volume":"123","author":"Warschkow","year":"2017","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.08.025_bib22","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","article-title":"Completeness of hospital cancer case reporting from the SEER program of the national cancer Institute","volume":"76","author":"Zippin","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.08.025_bib23","series-title":"National cancer Institute's the surveillance, Epidemiology, and End results (SEER) program","author":"Institute","year":"2021"},{"key":"10.1016\/j.ejso.2022.08.025_bib24","unstructured":"Association NCR. National cancer registrars association."},{"issue":"5","key":"10.1016\/j.ejso.2022.08.025_bib25","doi-asserted-by":"crossref","first-page":"580 e1","DOI":"10.1016\/j.ajog.2017.06.019","article-title":"Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer","volume":"217","author":"Matsuo","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.025_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000002142","article-title":"Risk of subsequent ovarian cancer after ovarian conservation in young women with stage I endometrioid endometrial cancer","volume":"130","author":"Matsuo","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"47","key":"10.1016\/j.ejso.2022.08.025_bib27","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","article-title":"Trends and outcomes of women with synchronous endometrial and ovarian cancer","volume":"9","author":"Matsuo","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ejso.2022.08.025_bib28","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2003.94.023","article-title":"The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies","volume":"21","author":"Harlan","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.025_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ije\/dyw040","article-title":"Outcome modelling strategies in epidemiology: traditional methods and basic alternatives","volume":"45","author":"Greenland","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"28","key":"10.1016\/j.ejso.2022.08.025_bib30","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.025_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.025_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat Res"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.025_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2022.08.025_bib34","series-title":"Abeloff's clinical Oncology","first-page":"1525","article-title":"Carcinoma of the ovaries and fallopian tubes","author":"Coleman","year":"2019"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.025_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:36Z","timestamp":1760060856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0748798322006321"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.025","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}